Page: Viable Diseases

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework allows, a wide range of point-of-care tests (POCT) can be carried out in community pharmacies. POCT can be incorporated into disease management programmes to monitor the effects of treatment in people living with non-communicable diseases. In addition, in acute situations, pharmacy professionals can use POCT to support clinical decision-making and provide rapid, safe pharmaceutical care. These tests provide valuable data to inform health-related decisions and reduce avoidable visits to primary care physicians or emergency departments. At this event, FIP will launch a global intelligence report on pharmacy-based point-of-care testing.

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.

Preventing new HIV infections is one of the most important steps towards curbing the HIV epidemic. Pharmacists are ideally placed to support prevention strategies that can reduce the risk of transmission, including advice on safer sex practices, supporting the use of pre- or post-exposure prophylaxis (PrEP/PEP) and supporting harm reduction strategies for intravenous drug users. Managing and optimising treatments in people living with HIV is another important way in which pharmacists can contribute. This event aims to explore options on how to assess and support patients, establish adherence strategies, manage side effects, provide counselling on lifestyle factors, and make appropriate referrals. Further, this event aims to provide skills to optimise HIV therapy, identify and resolve medication-related problems, collaborate with the care team, and empower patients to improve health outcomes.

The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.

At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the African region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.